Drug Shortage Report for PMS-ABACAVIR-LAMIVUDINE
Report ID | 38860 |
Drug Identification Number | 02458381 |
Brand name | PMS-ABACAVIR-LAMIVUDINE |
Common or Proper name | ABACAVIR-LAMIVUDINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ABACAVIR LAMIVUDINE |
Strength(s) | 600MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-02-02 |
Estimated end date | 2018-08-16 |
Actual end date | 2018-08-23 |
Shortage status | Resolved |
Updated date | 2018-08-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-02-06 | English | Compare |
v2 | 2018-02-06 | French | Compare |
v3 | 2018-08-24 | English | Compare |
v4 | 2018-08-24 | French | Compare |
Showing 1 to 4 of 4